Industry

The concentration of the novel coronavirus vaccine for children aged six to 11 is likely to be 10 times less than the parent Sputnik V for adults.

The Russian Direct Investment Fund (RDIF) expects that more than 150 million Sputnik COVID-19 coronavirus vaccines will be produced at factories in China per year.

The effectiveness of vaccines against coronavirus will drop significantly due to the emergence of a new strain of "omicron", said Stefan Bansel, CEO of Moderna.

These problems were reported by 74% of the companies that participated in the research.

The American Chamber of Commerce in Russia (AmCham) has applied to the US State Department with a request to recognize the Sputnik V vaccination certificates.

According to Rosstat, in January-September, the production of livestock and poultry meat decreased by 0.6%.

400 children aged 12-17 years in Moscow were vaccinated against coronavirus as part of clinical trials of the Sputnik-M vaccine.

According to the expert, pets can be a source of coronavirus infection for their owners.

Two Russian vaccines, developed using genetic technologies on the principle of the Sputnik V vaccine, are undergoing preclinical trials today.

The effectiveness of the Russian Sputnik V coronavirus vaccine after vaccination of 1.2 million people in Belarus was 96.3%.

The Russian vaccine has equaled the coverage in the world with Moderna, but is still inferior to Sinopharm and Pfizer.

Ural scientists are working on the creation of drugs for coronavirus, the Ural Federal University (UrFU) reported on Wednesday.

The head of the Ministry of Health of the Russian Federation, Mikhail Murashko, said that work with WHO on the recognition of the Russian vaccine against COVID-19 is moving in a positive direction.

According to the results of the first stage of research, the Sputnik V coronavirus vaccine for children forms good post-vaccination cellular immunity, the press service of the Moscow Mayor reports.

According to Alexander Gintsburg, vaccination with the Russian drug "Sputnik V", and then revaccination with a nasal drug, is likely to provide full protection from the severe course of COVID-19 and from coronavirus infection in general.